Although we identified a placebo-controlled RCT of a single nocturnal dose of 500 mcg TRH (n = 10) compared to normal saline (n = 10), to evaluate the antidepressant response in 20 bipolar depression patients [30], we decided not to include it in the review, as it is not available for clinical practice. This evidence concerns the gene TRH and bipolar disorder.